Sign in

Antonio Ciaccia

@aciaccia.bsky.social
878 followers 189 following 222 posts

Advocate for drug price transparency, competitive healthcare markets, & patient-centered care at 46brooklyn Research and 3 Axis Advisors. Dad to Franco, Marco, Vera, Enzo.

PostsRepliesMedia
Antonio Ciaccia @aciaccia.bsky.social · 30/09/2026
When you see the list of PBM rebate exclusions…
000
Antonio Ciaccia @aciaccia.bsky.social · 11/09/2026
The 340B program is an opaque, government-built spread pricing scheme that enriches all fortunate enough to wet their beaks on the arbitrage. For large, vertically-integrated PBM/TPA/pharmacy companies, 340B is an all-you-can-eat buffet. www.modernhealthcare.com/providers/mh...
modernhealthcare.com
110
Antonio Ciaccia @aciaccia.bsky.social · 07/09/2026
There are those who say PBM formularies don’t work. There are those who say PBM formularies work very well. And there are those who say PBM formularies work very well for themselves. What if they’re all right? @drugchannels.bsky.social www.drugchannels.net/2026/09/the-...
drugchannels.net
The Private Label Biosimilar Paradox in Medicare Part D
001
Antonio Ciaccia @aciaccia.bsky.social · 25/08/2026
“Opacity isn’t merely inconvenient. It can have economic value.” worldofdtcmarketing.com/information-...
worldofdtcmarketing.com
Information Asymmetry Is One of the Business Models Underlying American Healthcare
Mark Cuban is right. American healthcare suffers from transparency problems. Let’s be clear, though: Transparency problems are actually euphemisms for information asymmetry problems. Information asymm...
030
Antonio Ciaccia @aciaccia.bsky.social · 15/08/2026
CPI says health insurance prices are down 8% and drug prices are down 3.1%. Good luck finding a payer living that reality in their actual spend. Because CPI doesn't actually measure insurance premiums — and its prescription drug index is increasingly disconnected from where drug spending happens.
data4thepeople.com
Why Core CPI Isn't Measuring Real Health Care Inflation
CPI says health insurance costs fell 8% and drug prices 3.1% in 2026. Neither measures what you pay. We recalculated core inflation with real premium data.
011
Antonio Ciaccia @aciaccia.bsky.social · 09/08/2026
Great discussion with @chewsviews.bsky.social on the misaligned structure of the U.S. prescription drug supply chain and the bloated prices it is designed to yield. omny.fm/shows/chewsv...
omny.fm
WCPT 820 Interview: Antonio Ciaccia - Chew's Views with Richard Chew
Richard Chew is joined by Antonio Ciaccia, CEO and secretary of 46Brooklyn, Ohio-based nonprofit working to improve the accessibility and usability of U.S. drug pricing data. Catch "Chew's Views with...
011
Antonio Ciaccia @aciaccia.bsky.social · 27/07/2026
“DoD and Express Scripts say there is no spread pricing in the TRICARE contract, but the same language that Express Scripts used to milk other government plans out of millions of dollars is also present in TRICARE.” - @warren.senate.gov
federalnewsnetwork.com
Senate seeks to audit TRICARE pharmacy benefits program amid conflict concerns | Federal News Network
Express Scripts, the contractor that manages the TRICARE pharmacy program, also operates its own mail-order pharmacies that participate in the network.
001
Antonio Ciaccia @aciaccia.bsky.social · 25/07/2026
This will cause drug costs to rise. Period.
time.com
What Would Trump's Plan to Impose Tariffs on Generic Drugs Do to Prices?
Experts say that if Trump follows through, the proposed tariffs could have far-reaching consequences for the cost and availability of the medications.
001
Antonio Ciaccia @aciaccia.bsky.social · 20/07/2026
“It’s a shell game … Money was diverted from Medicaid to the PBM that should have gone to patient prescription delivery.” @pharmalot.bsky.social www.statnews.com/pharmalot/20...
statnews.com
State audit of Medicaid records points to methods used by PBMs to obscure drug costs
An audit of state Medicaid records revealed how PBMs are using complicated tactics for handling prescription drug claims that ultimately overcharge taxpayers.
001
Antonio Ciaccia @aciaccia.bsky.social · 18/07/2026
“How is it that a drug like abiraterone can be sold by @mcuban.bsky.social for less than 50 cents, while a PBM in the commercial market is selling it for $50 more?” The specialty drug marketplace is wrecked: www.46brooklyn.com/research/wre...
2432765
Antonio Ciaccia @aciaccia.bsky.social · 03/07/2026
Another manufacturer move to bypass the shoddy plumbing of the legacy drug channel endpoints.news/sandoz-launc...
endpoints.news
Sandoz tests direct-to-consumer sales with Omnitrope, a growth hormone biosimilar
Sandoz unveiled a direct-to-consumer platform, starting off with a single medication for now as the generic drugmaker adopts a system that several brand-name manufacturers are using to cut out-of-pock...
000
Antonio Ciaccia @aciaccia.bsky.social · 27/06/2026
Cassidy looks to put guardrails and limits on the 340B all-you-can-eat buffet @statnews.com www.statnews.com/2026/06/25/c...
statnews.com
Cassidy proposes bill to rein in 340B drug discount program
Placing new limits on the 340B drug discount program would be a fresh challenge for hospitals as they confront funding cuts.
000
Antonio Ciaccia @aciaccia.bsky.social · 25/06/2026
Launch prices for prescription drugs have come way down in the past year. Pricing problem solved? Hardly.
reuters.com
US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Launch prices for prescription medicines approved by U.S. regulators in 2025 fell from the previous year, but remained high at a ​median of $216,000 due to expensive drugs for rare diseases, a new ana...
001
Antonio Ciaccia @aciaccia.bsky.social · 11/06/2026
“Despite the fact that we made repeated requests and negotiated, the PBMs still at the end of the day withheld critical financial information … This lack of transparency is obviously a massive red flag.” - @robsandia.bsky.social
kmaland.com
Sand issues investigative report on PBM practices in Iowa
(Des Moines) -- A new report issued by the Iowa State Auditor's Office raises concerns over Pharmacy Benefit Managers' practices related to Iowa Medicaid.
010
Antonio Ciaccia @aciaccia.bsky.social · 11/06/2026
Great progress being made in Ohio to broaden patient access to testing and treatment for influenza, strep throat, and COVID-19 through local pharmacists. Good to see my home state knocking down unnecessary barriers to care. Much more to be done. ohiosenate.gov/members/mark...
ohiosenate.gov
Senate Passes Romanchuk Bill Expanding Patient Access To Flu, COVID Treatment
COLUMBUS-The Ohio Senate passed <a href="https://www.legislature.ohio.gov/legislation/136/SB230">Senate Bill 230</a>, sponsored by Senator Mark Romanchuk (R-Ontario), which authorizes pharmac...
000
Antonio Ciaccia @aciaccia.bsky.social · 09/06/2026
“When the true net price is determined through opaque, retrospective calculations controlled by others, purchasers are left with uncertainty, weaker accountability, and delayed value.” www.nationalalliancehealth.org/news/nationa...
nationalalliancehealth.org
National Alliance Releases New Guide to Help Employers Reduce Drug Pricing Volatility and Risk | National Alliance of Healthcare Purchaser Coalitions
Resource explains how retrospective discounts can drive uncertainty in pharmacy spendand offers practical steps purchasers can take now WASHINGTON – June 3, 2026 – The National Alliance of Healthcare ...
010
Antonio Ciaccia @aciaccia.bsky.social · 05/06/2026
In a world of bloated drug prices, negotiated discounts are where financial realities are forged But the ways those discounts are achieved are fraught with complication, conflict, opacity, and risk This new report shows why there’s growing pressure for change www.3axisadvisors.com/projects/a-m...
3axisadvisors.com
A Model of Financial Risk to Payers from Retrospective Drug Price Concessions — 3 ∆XIS Advisors
In an environment of inflated list prices for prescription drugs, in the United States, payers and patients rely upon significant negotiated discounts in order to afford and access medicines. These di...
000
Antonio Ciaccia @aciaccia.bsky.social · 19/05/2026
Most unlikely pairing I’ve seen since pineapple and pizza. www.notus.org/healthcare/t...
notus.org
TrumpRx Will Start Linking to Mark Cuban’s Discount Online Pharmacy
The White House’s drug pricing initiative will now feature generics, relying on Cost Plus Drugs and other drug discount companies.
000
Antonio Ciaccia @aciaccia.bsky.social · 13/05/2026
Optum says they are no longer going to arbitrage drug prices, so there you have it. www.modernhealthcare.com/insurance/mh...
modernhealthcare.com
UnitedHealth Group’s Optum Rx makeover elicits cautious welcome
UnitedHealth Group's Optum Rx joins rival pharmacy benefit managers by promising greater transparency.
000
Antonio Ciaccia @aciaccia.bsky.social · 10/05/2026
Until policymakers pop the bubble for good, expect the era of inflated drug prices to roll on kffhealthnews.org/health-care-...
kffhealthnews.org
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up. - KFF Health News
For all of President Donald Trump’s showmanship, the share of Americans his policies will likely help remains slim, even if some patients do come out ahead.
000
Antonio Ciaccia @aciaccia.bsky.social · 09/05/2026
Weight loss drugs heading to Amazon kiosks @nicoledefeudis.bsky.social endpoints.news/amazon-adds-...
endpoints.news
Amazon adds Ozempic pill to same-day prescription drug kiosks
Amazon has touted the kiosks as a convenient way for patients to get their prescriptions without even leaving the doctor’s office. But the machines don’t dispense substances that need to be refrigerat...
000
Antonio Ciaccia @aciaccia.bsky.social · 18/04/2026
The bill always comes due. www.usatoday.com/story/money/...
usatoday.com
How Trump's 100% drug tariffs could reach consumers pocketbooks
Drug price watchdogs worry President Donald Trump's plan to assess 100% tariffs on drug imports could lighten patients pocketbooks.
000
Antonio Ciaccia @aciaccia.bsky.social · 25/03/2026
Spread is dead. Long live the spread. ohiocapitaljournal.com/2026/03/25/c...
ohiocapitaljournal.com
CVS accused of overbilling feds $600M in scheme similar to one in Ohio • Ohio Capital Journal
A federal audit on Friday accused CVS's drug middleman of overcharging the Office of Personnel management $615 million between 2018 and 2021.
021
Antonio Ciaccia @aciaccia.bsky.social · 18/03/2026
TrumpRx launched with big promises on drug prices, but so far, it’s just 54 drugs – many with generics already cheaper elsewhere. Scale & transparency could make it useful. But now? Limited impact. Worth watching if it expands meaningfully. www.nbcnews.com/health/healt...
nbcnews.com
TrumpRx isn't doing much for drug prices. What would it take to change that?
So far, IVF drugs and GLP-1s have been the site's most commonly searched medications, representing a tiny fraction of the prescription drugs Americans take.
022
Antonio Ciaccia @aciaccia.bsky.social · 14/03/2026
“Report finds hospitals price the same cancer drugs up to 2000x apart, worsening financial toxicity and intensifying demands for real transparency.” www.targetedonc.com/view/new-rep...
targetedonc.com
New Report Reveals Major Variation in Hospital Pricing of Cancer Drugs | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Report finds hospitals price the same cancer drugs up to 2000x apart, worsening financial toxicity and intensifying demands for real transparency.
020
Antonio Ciaccia @aciaccia.bsky.social · 07/03/2026
“A 200-milligram dose of the cancer drug Keytruda ranged from $12,000 to $43,000, the research firm found through files published under the transparency rules.” www.axios.com/2026/03/05/d...
axios.com
Wide disparities found in hospitals' drug prices
Hospital pricing remains opaque, and the same drug at the same hospital can have a dozen different prices on the same day.
020
Antonio Ciaccia @aciaccia.bsky.social · 27/02/2026
"Drug prices are skyrocketing!" 🚀 "Drug prices are the lowest they've ever been!" 📉 Let's cut through the noise by looking at the actual numbers. Our latest: www.46brooklyn.com/news/trump-s...
46brooklyn.com
Trump says drug prices are going down. New data shows he’s right and wrong. — 46brooklyn Research
As a non-profit, we at 46brooklyn have made it our goal to provide insights into U.S. drug pricing data available in the public domain based upon the figures we’ve gathered over the prior month. Amids...
000
Antonio Ciaccia @aciaccia.bsky.social · 20/02/2026
You either want to fight high drug prices or you want to inflate them even more. New legislation from Senator Josh Hawley & @warren.senate.gov aims to get PBMs to pick a side. ohiocapitaljournal.com/2026/02/16/b...
ohiocapitaljournal.com
Bipartisan bill aims to end health conflicts and bring down costs after years of complaints in Ohio • Ohio Capital Journal
A bipartisan bill would prohibit health giants from providing services and paying for them. It would be the biggest antitrust law in decades.
001
Antonio Ciaccia @aciaccia.bsky.social · 11/02/2026
Extensive discussion with Virginia Focus on new year drug price changes, rebates, the push for domestic manufacturing, TrumpRx, the Inflation Reduction Act, 340B, PBMs, and the business of pharmacy www.iheart.com/podcast/1248...
iheart.com
Virginia Focus - Drug Pricing Update Virginia Focus | iHeart
The Trump administration has announced many changes to the prices of prescription drugs for Medicaid and Medicare as well as Trump RX, a website for people to get...
000
Antonio Ciaccia @aciaccia.bsky.social · 10/02/2026
The FTC has a proposed settlement agreement with Express Scripts over allegations of artificially inflating insulin prices. Will this be the start of a new era, or will we continue to see old money harvested in new ways?
statnews.com
FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
The FTC settled a lawsuit against Express Scripts over allegations that the company artificially inflated the price of insulin and impeded access to treatment.
001
Antonio Ciaccia @aciaccia.bsky.social · 29/01/2026
Good coverage from @loftus.bsky.social on the latest moves on brand drug list prices and how those hikes and cuts could impact patients and broader prescription drug spending www.wsj.com/health/pharm...
wsj.com
This Year Drugmakers Cut Prices for Several Widely Used Drugs
Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.
000
Antonio Ciaccia @aciaccia.bsky.social · 25/01/2026
Brand drug list prices are on the move this month. Here’s good recent coverage of some of the latest spikes and cuts from @usatoday.com: www.usatoday.com/story/money/...
usatoday.com
Drugmakers hike medicine prices in 2026. How much more will you spend?
Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug prices.
001
Antonio Ciaccia @aciaccia.bsky.social · 24/01/2026
More NPR coverage of 2026 brand drug list price changes from @sydneylupkin.bsky.social: www.npr.org/2026/01/16/n...
npr.org
Trump struck deals with 16 drug companies. But they're still raising prices this year
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.
012
Antonio Ciaccia @aciaccia.bsky.social · 31/12/2025
New year, new drug prices 💊 Get a sneak peak at some of the early 2026 drugmaker list price hikes – and cuts – in an era of arguably unprecedented drug channel change. www.reuters.com/business/hea...
reuters.com
Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump
Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration p...
021
Antonio Ciaccia @aciaccia.bsky.social · 23/12/2025
“Transparency can end up meaning a presentation of numbers and terms that looks detailed but still doesn't reveal what's really driving employer costs, creating an appearance of openness that protects the status quo instead of enabling real accountability.” www.benefitspro.com/2025/12/23/p...
benefitspro.com
Prescription benefits clarity is about more than transparency
Getting a list of what the drugs cost is just the start.
022
Antonio Ciaccia @aciaccia.bsky.social · 22/12/2025
A often-overlooked fallout of our fragmented drug distribution system: patients with too many medicines, too many prescribers, too many pharmacies, and not enough quarterbacking of the entirety of the patient’s treatment journey. www.wsj.com/health/healt...
wsj.com
America’s Seniors Are Overmedicated
One in six seniors enrolled in Medicare’s drug benefit were prescribed eight or more medications at the same time, an analysis of Medicare data found.
021
Antonio Ciaccia @aciaccia.bsky.social · 05/12/2025
The market won't change until employers start changing. And slowly but surely, employers are starting to change. www.healthcare-brew.com/stories/2025...
healthcare-brew.com
Eli Lilly switches from Big 3 PBM to alternative transparent rival
The drugmaker has about 23,000 employees who will be covered by Rightway.
011
Antonio Ciaccia @aciaccia.bsky.social · 04/12/2025
Now that Congress is back to some degree of normal business, drug pricing reforms are back in the hopper with @mikecrapo.bsky.social and @wyden.senate.gov’s long-anticipated PBM reform policy package now hitting Senate desks www.finance.senate.gov/ranking-memb...
finance.senate.gov
Wyden, Crapo Introduce Bipartisan Pharmacy Benefit Manager Legislation | The United States Senate Committee on Finance
Wyden, Crapo Introduce Bipartisan Pharmacy Benefit Manager Legislation
010
Antonio Ciaccia @aciaccia.bsky.social · 28/11/2025
“That sounds criminal.” Great chatting by with Paul Miller at WPHM about bloated prescription drug prices and how our reliance on conflicted intermediaries to control them can often make affordability issues even worse www.wphm.net/episode/nove...
wphm.net
November 26 Antonio Ciaccia
Rising prescription drug prices
010
Antonio Ciaccia @aciaccia.bsky.social · 26/11/2025
In just a few months' time, Rite Aid and Fruth Pharmacies have been wiped off the map @martyschladen.bsky.social ohiocapitaljournal.com/2025/11/26/p...
ohiocapitaljournal.com
Pharmacy chain closes, worsening deserts in SE Ohio, West Virginia • Ohio Capital Journal
Blaming giant drug middlemen, Fruth Pharmacy is closing its stores in southeastern Ohio and West Virginia after 73 years in business.
000
Antonio Ciaccia @aciaccia.bsky.social · 20/11/2025
The waves of community pharmacy closures keep coming; this time it’s my good friends over at Fruth Pharmacy. More neighborhoods of need in Ohio and West Virginia turning into pharmacy deserts. Another reminder that you get what you pay for. wchstv.com/news/local/f...
wchstv.com
Fruth to sell its pharmacies to Walgreens by the end of the year
A pharmacy chain that has served the region for decades has announced it is selling its practices.Fruth Pharmacy announced this week that it will sell its pharm
030
Antonio Ciaccia @aciaccia.bsky.social · 11/11/2025
I will give you an 80% discount off the price of your cup of coffee. Sounds great, right? Let's sign a contract where all your coffee purchases go through me, and I will honor that 80% discount every time. BTW, I also set the price of that coffee.
46brooklyn.com
This drug pricing distortion was supposed to go extinct. It’s never been more alive. — 46brooklyn Research
This summer, we launched a new research work that examined the costs yielded by a reborn and evolved species of the prescription drug supply chain: drug companies who are also part of larger vertica...
071
Antonio Ciaccia @aciaccia.bsky.social · 07/11/2025
PBMs say they want low list prices for drugs. Their new affiliated private label drug companies now have the power to do it themselves. Instead, the generic prices are on average 33 times higher than the lowest in the market. www.bloomberg.com/news/article...
bloomberg.com
Cigna Unit Sells Generic Drugs at Higher Prices, Report Says
A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role...
072
Antonio Ciaccia @aciaccia.bsky.social · 06/11/2025
Everyone says they want low drug prices until actual low drug prices show up. (except patients) @costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...
statnews.com
Mark Cuban is trying to shake up biosimilar pricing with a version of J&J's best-selling Stelara drug
In its bid to shake up drug pricing, the Mark Cuban Cost Plus Drug Company has reached a deal to sell a biosimilar version of Stelara, a widely prescribed treatment.
001
Antonio Ciaccia @aciaccia.bsky.social · 03/11/2025
You don’t say?
statnews.com
UnitedHealth pays its own physician groups 17% more than outside ones, study shows
The findings are similar to an analysis STAT conducted, and raise questions about why UnitedHealth pays its doctors more.
020
Antonio Ciaccia @aciaccia.bsky.social · 13/10/2025
From Big 3 to just zero: Rite Aid is officially reduced to ashes as pharmacy market attrition rolls on @martyschladen.bsky.social ohiocapitaljournal.com/2025/10/13/a...
ohiocapitaljournal.com
After bailing on Ohio and Michigan, Rite Aid closes completely  • Ohio Capital Journal
A wave of pharmacy closures in Ohio and elsewhere appears to be deepening. Once the third-largest pharmacy chain in the United States, Rite Aid announced on its website that all of its stores are now ...
011
Antonio Ciaccia @aciaccia.bsky.social · 13/10/2025
“Soaking high drug prices as a mechanism to lower premiums is neither a wise nor a sustainable practice.” Acknowledge @repauchincloss.bsky.social 🎙️ www.realpharma.co/where-policy...
realpharma.co
Where Policy Meets the Pharmacy Counter
Where Policy Meets the Pharmacy Counter Featuring Congressman Jake Auchincloss Episode Summary In this episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down…
000
Antonio Ciaccia @aciaccia.bsky.social · 09/10/2025
When Amazon makes moves in pharmacy – no matter how seemingly small – you should always be thinking about the long game @nyeungs.bsky.social endpoints.news/whats-behind...
endpoints.news
What's behind Amazon’s in-person pharmacy play
Amazon to install prescription medication dispensing machines at One Medical clinics, starting in Los Angeles this December, marking its first in-person pharmacy presence.
000
Antonio Ciaccia @aciaccia.bsky.social · 09/10/2025
Good news for fans of generic drug affordability 👇 www.wsj.com/health/pharm...
wsj.com
Exclusive | Trump Excludes Generics From Big Pharma Tariff Plan
The administration has been weighing duties for months on a range of products and ingredients in a national-security tariff investigation.
000
Antonio Ciaccia @aciaccia.bsky.social · 09/10/2025
“American businesses should not be left to subsidize the lack of transparency, accountability and fair competition in the health care industry.” www.washingtontimes.com/news/2025/oc...
washingtontimes.com
Congress must address the health care cost crisis now
Our health care system has a pressing need for greater competition and transparency.
000